Divis Laboratories Q1 Results FY27: PAT at Rs 902 Cr for June 2026 Quarter
- August 3, 2026
- Posted by: Ankit Jaiswal
- Category: News
Divis Laboratories Q1 FY27: PAT Rs 902 Cr, +65.50% YoY. Revenue Rs 3,080 Cr, +27.80% YoY. Stock at Rs 8,085 (up 0.36%).
The Divis Laboratories Q1 results FY27 show consolidated revenue of Rs 3,080 Cr for the quarter ended 30 June 2026, +27.80% from Rs 2,410 Cr in Q1 FY26, as Divis Laboratories reported its numbers on 1 August 2026.
Divis Laboratories posted a net profit (PAT) of Rs 902 Cr for the quarter, against Rs 545 Cr a year earlier. Shares traded around Rs 8,085 on the NSE, up 0.36% on the day, as investors weighed the print against trends in the broader market. Here is a full breakdown of the financial highlights, key business factors, dividend status, outlook and risks.
Click Here – Get Free Investment Predictions
Divis Laboratories Q1 Results FY27 Financial Highlights
The table below summarises Divis Laboratories’s consolidated numbers for the quarter against the year ago period.
| Metric | Q1 FY27 (Jun 2026) | Q1 FY26 (Jun 2025) | YoY Change |
|---|---|---|---|
| Revenue | Rs 3,080 Cr | Rs 2,410 Cr | +27.80% |
| Gross Profit | Rs 1,122 Cr | Rs 617 Cr | +81.85% |
| Gross Profit Margin | 36.4% | 25.6% | +10.8 pts |
| Net Profit (PAT) | Rs 902 Cr | Rs 545 Cr | +65.50% |
| Net Profit Margin | 29.3% | 22.6% | +6.7 pts |
Divis Laboratories Q1 FY27 Performance Analysis
Revenue growth was the standout number for the quarter. Sales rose +27.80% year on year to Rs 3,080 Cr, up from Rs 2,410 Cr in the year ago period, as demand held firm through the June quarter.
Margins expanded through the June quarter. Gross profit rose +81.85% year on year to Rs 1,122 Cr (36.4% margin), a faster clip than the revenue increase, which points to better cost absorption.
Profit after tax rose +65.50% year on year to Rs 902 Cr against Rs 545 Cr a year earlier, a healthy improvement in earnings for the quarter.
Check the Univest Screener for Live Data
Divis Laboratories Q1 FY27: Key Business Factors
1. Revenue Growth Trajectory
Divis Laboratories reported revenue of Rs 3,080 Cr for the June 2026 quarter against Rs 2,410 Cr in the year ago period, a change of +27.80%. This pace of change is a primary swing factor behind the quarter’s numbers, and investors typically track whether it holds up in the following quarters.
2. Gross Margin and Cost Trends
Gross profit moved from Rs 617 Cr in Q1 FY26 to Rs 1,122 Cr in Q1 FY27, a change of +81.85%. In the broader market, this line is sensitive to input cost movements, demand cyclicality and competitive intensity, and this quarter’s numbers reflect how Divis Laboratories managed that balance.
3. Bottom Line and Earnings Quality
Net profit moved from Rs 545 Cr in Q1 FY26 to Rs 902 Cr this quarter, up +65.50%. On a reported basis this is the figure that flows through to earnings per share, and it is usually the first number investors check.
Dividend Details
Specific dividend information was not confirmed as part of this results snapshot. Investors should check the official exchange filing on the NSE or BSE website, or track the Univest Screener, for the latest dividend announcement, record date and payment date from Divis Laboratories.
Divis Laboratories Outlook for FY27
This quarter sets the tone for the rest of FY27. If the growth in revenue and improvement in net profit persist, analysts are likely to revisit their FY27 estimates for Divis Laboratories. Investors should also watch input costs and demand trends in the broader market through the year.
Divis Laboratories Stock Performance After the Results
Divis Laboratories shares traded around Rs 8,085 on the NSE, up 0.36% around the time the results were in focus. The 52 week trading range was not confirmed as part of this snapshot; investors can check the live 52 week high and low, along with technical levels, on the Univest Screener before making any trading decision.
Download the Univest iOS App or Univest Android App to track Divis Laboratories live share price and upcoming quarterly results.
Key Risks
Investors reading through Divis Laboratories’s numbers should also weigh the following risks.
1. Margin and Input Cost Risk
Being in the broader market, Divis Laboratories remains exposed to input cost movements, demand cyclicality and competitive intensity. A reversal in the trend seen this quarter could pressure margins in coming quarters.
2. Execution and Working Capital Risk
Execution risk around working capital, receivables and order timelines can cause quarter to quarter volatility in reported numbers, so this quarter’s trends should be read over a few quarters rather than in isolation.
3. Macro and Sector Risk
Broader macro factors including interest rates, currency movements and demand cycles in the broader market could influence how sustainable this quarter’s trends prove to be over FY27.
Conclusion
The Divis Laboratories Q1 results FY27 show revenue of Rs 3,080 Cr and Rs 902 Cr for the quarter, against Rs 2,410 Cr and Rs 545 Cr in Q1 FY26. Revenue growth and a stronger bottom line were the two moving parts this quarter. Investors tracking Divis Laboratories should watch the next few quarters for confirmation of this trend and consult a SEBI-registered advisor before making investment decisions based on these numbers.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Divis Laboratories Q1 Results FY27
When were the Divis Laboratories Q1 results FY27 announced?
Ans. They reflect the quarter ended 30 June 2026, with the data reported as of 1 August 2026. Investors should confirm the exact board meeting date from the official NSE or BSE filing.
What is the PAT in Divis Laboratories’s Q1 FY27 results?
Ans. The PAT stood at Rs 902 Cr, compared with Rs 545 Cr in Q1 FY26, a change of +65.50%.
What was the revenue in Divis Laboratories’s Q1 FY27 results?
Ans. Revenue came in at Rs 3,080 Cr for the quarter, a change of +27.80%, compared with Rs 2,410 Cr in Q1 FY26.
Did Divis Laboratories declare a dividend with the Q1 FY27 results?
Ans. Dividend details were not confirmed as part of this results snapshot. Check the latest exchange filing on NSE or BSE, or the Univest Screener, for confirmation.
What is the outlook for Divis Laboratories after Q1 FY27?
Ans. Analysts will track whether the growth in revenue and improvement in profit continue into the September 2026 quarter, along with input cost and demand trends in the broader market.
How did the stock react to Divis Laboratories’s Q1 FY27 results?
Ans. Shares traded around Rs 8,085 on the NSE, up 0.36% as the numbers came into focus.
Is Divis Laboratories a good buy after the Q1 FY27 results?
Ans. The quarter shows a net profit of Rs 902 Cr on revenue of Rs 3,080 Cr. This article is for educational purposes only and is not investment advice. Consult a SEBI-registered advisor before making any investment decision.
